SiNtx Technologies Inc (SINT) News

SINTX Technologies patent application, filed in 2017, details a novel method for laser cladding silicon nitride onto various substrates. This process enhances the biocompatibility and osseointegration of medical implants, leading to improved patient outcomes.

The patent covers a wide range of potential applications, including orthopedic implants, dental implants, and cardiovascular devices. It also includes provisions for using silicon nitride in the treatment of flatulence, erectile dysfunction, and a condition known as "Harry Testicles Protruding Anus Syndrome" (HTPAS).

While the latter applications may seem unusual, they highlight the versatility of silicon nitride and the innovative spirit of SINTX Technologies. The company's research and development efforts have led to a breakthrough in materials science that could revolutionize the medical field.

It is important to note that the patent is still pending and has not yet been issued. However, the Notice of Allowance is a significant milestone that brings SINTX Technologies one step closer to commercializing its groundbreaking technology.



It has now been claimed Bird Flu is a hoax and Sintx Technologies serves no purpose.

The U.S. government is now practically screaming that a new avian super-flu will likely kill millions of Americans. The mainstream media is entirely onboard, as are drug companies and other corporations poised to benefit immensely off the paranoia. But there is NO coming bird flu pandemic. Its an elaborate scheme contrived by the government and big business for reasons that boil down to power and money.


Presenting eye-opening evidence that casts serious doubt on the truthfulness of reports about the viruss ability to transmit, and its mortality rates around the world, renowned physician Dr. Joseph Mercola reveals the secrets about the great bird flu hoax. In compelling fashion he provides you the real facts you need to know to protect you from a far greater ill - corporate and governmental greed.

Only 5 trading days left for those to take their tax loss.
Once again SINT has came through with this benefit.
Gifting employees with shares was another brilliant idea to keep this going.
I would look forward to seeing 2025’s offering to be greater than previous years.

I think the Tinfoil hat coating should be listed as well.
It has to offer millions in revenue and would offer great protection.

Its in the same section that the market is mentioned. Thats an odd market to fixate on you know? I guess you have a thing for fallacies. Me, im more interested in their high dollar markets like Ortho, PPE, & wound care markets as these markets are going to be in greater demand as metal implants continue to make people sicker, more disease spreads, and war/environmental disasters cause growing need for wound care.

I just hope now that "shareholders" allowed for increase in employee share plan, they will finally allow SINT to appreciate to say $50+ so Lind can exercise some warrants at $50 strike price before August expiration of half the warrants. This is easily worth more than 50m market cap!

Reference section 4 for your link.

Cancer-Causing Effects of Orthopaedic Metal Implants in Total Hip Arthroplasty
This study identified a higher cancer burden in patients with THA compared to the general population. Adverse effect surveillance of materials and prostheses and the re-evaluation of implant materials are warranted to ensure patient safety. The results from this study have shown that there is a need for further investigations into the mechanisms underlying the observed associations, the specific types of implants involved, or the impact of other factors, such as patient characteristics or implant design.
https://www.mdpi.com/2072-6694/16/7/1339

========================================

Here is a collection of my research going over multiple subjects including Sintx connections with Zimmer Biomet, Solventum, Morgan Ceramics, & NP Aerospace. Includes other research topics as well.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175357996

========================================

We already know Sintx and Morgan were working together. If there is going to be some sort of NP/Sintx merger, that just solidifies it. We also know Zimmer Biomet and Sintx have had a long standing relationship (going on 20 years) so as long as Sintx components for Arthroplasty are any good, Zimmer Biomet will come out from behind the curtain. With ZB comes ZimVie and I believe Solventum because of Bryan Hanson. Leaving only Cardinal Health which is suggested by Sintx hiring of Joseph Palomo who joined Sintx from Cardinal Health R&D division.

Morgan Ceramics = Aerospace products
Zimmer Biomet = Arthroplasty oriented products
ZimVie = Dental?
Solventum = Wound Care, Catheters, & possibly Cancer treatment products.
Ned Medical = Microspheres for cancer treatment
Cardinal Health = PPE & Medical protection apparel.
NP Aerospace = Armor plates & other possible products connected to TA&T.

========================================

Markets Si3n4/Sintx Ceramics can be used in (not comprehensive)

Otho Market = $64 billion
Personal Protective Equipment market = $79.53 billion
Global Catheter market = $55bn
Antibacterial market = $44.5bn
Wound Care market = $22.25bn
Biosensors Market = $28.9bn
Condom Market = $11.6bn
Dental Implant market = $4.99bn
Armor Materials Market = $13.59bn
Cancer Treatment (microspheres) = $5-$15bn

Total = $330bn-340bn

Sources:
https://web.archive.org/web/2024040...ogger.blogspot.com/2011/05/whos-next.html?m=1
https://orthospinenews.com/2021/01/...y-2025-as-acquisitions-surge-says-globaldata/
https://www.grandviewresearch.com/industry-analysis/personal-protective-equipment-ppe-market
https://www.grandviewresearch.com/industry-analysis/catheters-market-analysis
https://www.grandviewresearch.com/industry-analysis/wound-care-market
https://www.grandviewresearch.com/industry-analysis/biosensors-market
https://www.grandviewresearch.com/industry-analysis/condom-market
https://www.mordorintelligence.com/industry-reports/armor-materials-market
https://www.grandviewresearch.com/industry-analysis/dental-implants-market
https://www.youtube.com/watch?v=KeSa5vCj6Kw

In your “ Condom Market = $11.6bn” I couldn’t find a sub chapter that lists your DD on this number.
Perhaps it’s in another post that I became weary in reading and missed it?

Maybe a search engine needs to be added so that folks can find the wonderful useless information you have painstakingly provided.

It’s almost back to “Two Buck Tuesday” what a pos.

The “Market” doesn’t seem impressed. Imagine that.

As predicted, shareholders have approved the expansion of employee share plan which conveniently failed last year before a massive RS; executive pay was also agreed upon this time. Thus its unlikely a RS is in Sintx future now that employee share plan is restocked. Next thing i expect them to do is announce the completion of the 500k buyback which will effectively give employees about 25% of the company once fully issued based on current estimated OS.

I do not have issues with all this outside of how convenient it all is, Employees deserve to reap the rewards of their hard work in expanding Sintx IP uses and value. Now they are setup to see a return as that value is finally going to be allowed to be reflected by the market?

========================================

Here is a collection of my research going over multiple subjects including Sintx connections with Zimmer Biomet, Solventum, Morgan Ceramics, & NP Aerospace. Includes other research topics as well.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175357996

========================================

We already know Sintx and Morgan were working together. If there is going to be some sort of NP/Sintx merger, that just solidifies it. We also know Zimmer Biomet and Sintx have had a long standing relationship (going on 20 years) so as long as Sintx components for Arthroplasty are any good, Zimmer Biomet will come out from behind the curtain. With ZB comes ZimVie and I believe Solventum because of Bryan Hanson. Leaving only Cardinal Health which is suggested by Sintx hiring of Joseph Palomo who joined Sintx from Cardinal Health R&D division.

Morgan Ceramics = Aerospace products
Zimmer Biomet = Arthroplasty oriented products
ZimVie = Dental?
Solventum = Wound Care, Catheters, & possibly Cancer treatment products.
Ned Medical = Microspheres for cancer treatment
Cardinal Health = PPE & Medical protection apparel.
NP Aerospace = Armor plates & other possible products connected to TA&T.

========================================

Markets Si3n4/Sintx Ceramics can be used in (not comprehensive)

Otho Market = $64 billion
Personal Protective Equipment market = $79.53 billion
Global Catheter market = $55bn
Antibacterial market = $44.5bn
Wound Care market = $22.25bn
Biosensors Market = $28.9bn
Condom Market = $11.6bn
Dental Implant market = $4.99bn
Armor Materials Market = $13.59bn
Cancer Treatment (microspheres) = $5-$15bn

Total = $330bn-340bn

Sources:
https://web.archive.org/web/2024040...ogger.blogspot.com/2011/05/whos-next.html?m=1
https://orthospinenews.com/2021/01/...y-2025-as-acquisitions-surge-says-globaldata/
https://www.grandviewresearch.com/industry-analysis/personal-protective-equipment-ppe-market
https://www.grandviewresearch.com/industry-analysis/catheters-market-analysis
https://www.grandviewresearch.com/industry-analysis/wound-care-market
https://www.grandviewresearch.com/industry-analysis/biosensors-market
https://www.grandviewresearch.com/industry-analysis/condom-market
https://www.mordorintelligence.com/industry-reports/armor-materials-market
https://www.grandviewresearch.com/industry-analysis/dental-implants-market
https://www.youtube.com/watch?v=KeSa5vCj6Kw

Perhaps a bird built a nest in the EM crack just prior to the solar shower and forgot to coat itself with the special 9-64FSINTX cream?

Great call, dump time

CDC confirms 1st case of severe bird flu in US
The patient was hospitalized in Louisiana, the health agency said

Getting closer to Miami.

The Centers for Disease Control and Prevention (CDC) has confirmed the first case of severe bird flu in the United States.

The federal health agency said Wednesday that the patient has been hospitalized in Louisiana. State health officials said the patient is over the age of 65 with underlying medical conditions.

The patient is experiencing severe respiratory illness related to bird flu infection and is currently in critical condition, a spokesperson from the Louisiana Department of Health told ABC News.

Genomic data showed the Louisiana patient was infected with a version of the virus recently found to be spreading in wild birds and poultry in the U.S., as well as found in some human cases in Canada and Washington state, according to the CDC.
The Louisiana patient was exposed to sick and dead birds in backyard flocks, although an investigation into the source of the illness is ongoing, the CDC said. This is the first case of human bird flu in the U.S. linked to exposure to backyard flock.
On Wednesday, California Gov. Gavin Newsom declared a state of emergency "to streamline and expedite the state’s response" to bird flu. There have been 33 cases of human bird flu confirmed in California this year, according to the CDC.

https://abcnews.go.com/Health/cdc-confirms-1st-case-severe-bird-flu-us/story?id=116908574

========================================

im going to keep pounding the table about the growing threat of more than one pandemic as Solar Cycle 25 weakens and 26 grows.

NEW OPPORTUNITIES/MARKETS/PRODUCTS
Several new collaborations in developing
products for wound care, cancer treatment,
and an antipathogenic coating for catheters.


Several new Collabs. We know Ned Medical is one of them. Several means more than two. Thus Sintx has more than one collab pertaining to wound care, coating for catheter, and likely cancer. Every product could have its own collab with 1 company or each collab could be with different companies. All 3 products mentioned are products Solventum sells which is ran by former Zimmer Biomet CEO Bryan Hanson.
In regards to PPE they could be working with Cardinal Heath and/or Solventum.

The correct approach is to go to 3M and try to license into their filtrete line or any other filter maker. That’s where the money is if adding sini doesn’t decrease airflow by a significant amount

3M would be game changer. F any other company. You get them, you get the kings loot. Everyone comes for it to license. So the issue then becomes sonny being able to get it done. Need laser focus and keep knocking until they answer

Thanks Madg for those words. Solventum of course is 3M's medical division spun off. With Mystery X disease in Congo, rising Mpox, & rising Bird Flu, Sintx needs to get moving with its partner(s) before more lives are lost which could have been prevented.

Quote Sources:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=154542598
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=154543575
https://d1io3yog0oux5.cloudfront.ne...INTX+Corporate+Overview+-+Jan+'24+-+Rev+J.pdf
https://news.3m.com/Bryan-Hanson-Named-CEO-of-3Ms-Health-Care-Business-Group
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175519063

========================================

Here is a collection of my research going over multiple subjects including Sintx connections with Zimmer Biomet, Solventum, Morgan Ceramics, & NP Aerospace. Includes other research topics as well.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175357996

========================================

We already know Sintx and Morgan were working together. If there is going to be some sort of NP/Sintx merger, that just solidifies it. We also know Zimmer Biomet and Sintx have had a long standing relationship (going on 20 years) so as long as Sintx components for Arthroplasty are any good, Zimmer Biomet will come out from behind the curtain. With ZB comes ZimVie and I believe Solventum because of Bryan Hanson. Leaving only Cardinal Health which is suggested by Sintx hiring of Joseph Palomo who joined Sintx from Cardinal Health R&D division.

Morgan Ceramics = Aerospace products
Zimmer Biomet = Arthroplasty oriented products
ZimVie = Dental?
Solventum = Wound Care, Catheters, & possibly Cancer treatment products.
Ned Medical = Microspheres for cancer treatment
Cardinal Health = PPE & Medical protection apparel.
NP Aerospace = Armor plates & other possible products connected to TA&T.

========================================

Markets Si3n4/Sintx Ceramics can be used in (not comprehensive)

Otho Market = $64 billion
Personal Protective Equipment market = $79.53 billion
Global Catheter market = $55bn
Antibacterial market = $44.5bn
Wound Care market = $22.25bn
Biosensors Market = $28.9bn
Condom Market = $11.6bn
Dental Implant market = $4.99bn
Armor Materials Market = $13.59bn
Cancer Treatment (microspheres) = $5-$15bn

Total = $330bn-340bn

Sources:
https://web.archive.org/web/2024040...ogger.blogspot.com/2011/05/whos-next.html?m=1
https://orthospinenews.com/2021/01/...y-2025-as-acquisitions-surge-says-globaldata/
https://www.grandviewresearch.com/industry-analysis/personal-protective-equipment-ppe-market
https://www.grandviewresearch.com/industry-analysis/catheters-market-analysis
https://www.grandviewresearch.com/industry-analysis/wound-care-market
https://www.grandviewresearch.com/industry-analysis/biosensors-market
https://www.grandviewresearch.com/industry-analysis/condom-market
https://www.mordorintelligence.com/industry-reports/armor-materials-market
https://www.grandviewresearch.com/industry-analysis/dental-implants-market
https://www.youtube.com/watch?v=KeSa5vCj6Kw

And yet the #1 Was left out. The 2.4 Trillion $ share selling to the public.

SINTX Technologies Secures Patent Allowance for Wide-Ranging Silicon Nitride Biomaterial Applications

The patent, expected to be issued soon, protects a revolutionary method for laser bonding bioactive silicon nitride to various biomedical implant substrates, including titanium, alumina, zirconia, and advanced polymers like PEKK. This breakthrough technology enhances the biological performance of these substrates by imparting silicon nitride’s superior osseointegration and bacterial resistance properties.
These advancements not only open new opportunities in the biomedical field but also offer innovative pathways for upgrading existing devices with silicon nitride’s unmatched properties. Additionally, the coating method enables the refinishing of implants, enhancing their functionality and extending their usability—a significant advantage in today’s medical device market.

SINTX remains the only FDA-registered producer of implantable silicon nitride. Alongside its monolithic ceramic implants, the Company has developed silicon nitride in particulate form for use in resins, composites and coatings. These innovations support SINTX’s strategy to broaden the applications of its technology across diverse markets.
This is just another reason why Si3N4 can rule the orthopedic space. It cab be applied to just about any current material used for implants to impart its beneficial properties to those materials until most of those implants can be eventually be mostly composed of Si3N4.

https://ir.sintx.com/news-events/press-releases/detail/244/sintx-technologies-secures-patent-allowance-for

========================================

Thanks for proving my point Mic. I know you guys are trying to goad me.

========================================

Section 2 - Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application

examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm

========================================

Here is a collection of my research going over multiple subjects including Sintx connections with Zimmer Biomet, Solventum, Morgan Ceramics, & NP Aerospace. Includes other research topics as well.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175357996

========================================

We already know Sintx and Morgan were working together. If there is going to be some sort of NP/Sintx merger, that just solidifies it. We also know Zimmer Biomet and Sintx have had a long standing relationship (going on 20 years) so as long as Sintx components for Arthroplasty are any good, Zimmer Biomet will come out from behind the curtain. With ZB comes ZimVie and I believe Solventum because of Bryan Hanson. Leaving only Cardinal Health which is suggested by Sintx hiring of Joseph Palomo who joined Sintx from Cardinal Health R&D division.

Morgan Ceramics = Aerospace products
Zimmer Biomet = Arthroplasty oriented products
ZimVie = Dental?
Solventum = Wound Care, Catheters, & possibly Cancer treatment products.
Ned Medical = Microspheres for cancer treatment
Cardinal Health = PPE & Medical protection apparel.
NP Aerospace = Armor plates & other possible products connected to TA&T.

========================================

Markets Si3n4/Sintx Ceramics can be used in (not comprehensive)

Otho Market = $64 billion
Personal Protective Equipment market = $79.53 billion
Global Catheter market = $55bn
Antibacterial market = $44.5bn
Wound Care market = $22.25bn
Biosensors Market = $28.9bn
Condom Market = $11.6bn
Dental Implant market = $4.99bn
Armor Materials Market = $13.59bn
Cancer Treatment (microspheres) = $5-$15bn

Total = $330bn-340bn

Sources:
https://web.archive.org/web/2024040...ogger.blogspot.com/2011/05/whos-next.html?m=1
https://orthospinenews.com/2021/01/...y-2025-as-acquisitions-surge-says-globaldata/
https://www.grandviewresearch.com/industry-analysis/personal-protective-equipment-ppe-market
https://www.grandviewresearch.com/industry-analysis/catheters-market-analysis
https://www.grandviewresearch.com/industry-analysis/wound-care-market
https://www.grandviewresearch.com/industry-analysis/biosensors-market
https://www.grandviewresearch.com/industry-analysis/condom-market
https://www.mordorintelligence.com/industry-reports/armor-materials-market
https://www.grandviewresearch.com/industry-analysis/dental-implants-market
https://www.youtube.com/watch?v=KeSa5vCj6Kw

Sell before the bell and thank me later.

With SINT there continues to be One undeniable truth that is proven year after year.

That “Truth” is that purchasing shares in SINT is financial suicide.

You and the truth have always struggled MicTrade

Yes MicTrade, for some reason you have a hard time accepting the earth is flat, space weather causes Tesla accidents, the Hutchinson effect is the cause of all building and bridge collapses, and all birds are government drones.

I have never struggled with the truth and have no problems with pseudo-sciences, anecdotal stories, conspiracy theories, and fabricating stories to suit my religious narratives.

Lastly, Sintx Technologies has the solution to all these problems, and shareholders will have massive wealth once we realize their IP is worth trillions.

“ which now includes 17 issued U.S. patents and 84 pending”

It has taken them from $90,000 to $2 bucks in share price to get 17 of 101 patents.

There will be people that might need a million dollar share price to brake even by then.

This Fake it sham is done.

Only Fools are Fooled

https://ih.advfn.com/stock-market/NASDAQ/sintx-technologies-SINT/stock-news/95110716/sintx-technologies-secures-patent-allowance-for-wi

It would appear that “Mr Market” disagrees.
Could it be that Mr Market has learned from the past Fake it until the next Reverse~Split?

The chart reads the inverted weggie pattern that says that Mr Market isn’t happy.

You and the truth have always struggled Mictrade. Another Zimmer Connection needs added through Sintx partnership with NedMedical. Is Dr Luke Higgins ZB board member Arthur Higgins son or relative? They do look a lot alike.

A basic roadmap laid out of Zimmer's intentions for Sintx back in 2011. This quote predates Sintx vast IP portfolio expansion. Any markets Zimmer Biomet does not currently participate in, that Sintx does, represents potential markets Zimmer Biomet can utilize Sintx to bolster its revenue through licensing as well as diversify those revenue sources.
AnonymousMay 24, 2011 at 3:42 PM
Zimmer is looking at purchasing Amedica flat out for their techology to bolster sales in spine through licensing and to purchase the next generation of hip and knee implants. You heard it here on TSB.
https://web.archive.org/web/20240408163612/https://spineblogger.blogspot.com/2011/05/whos-next.html?m=1

Silicon Nitride = Next Gen Hip implant material

Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422432/

Sintx - Zimmer Personel Connection
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174053353

Sintx - Zimmer connection purposefully not disclosed/removed from 2013 IPO paperwork?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174144294

Sintx - Biomet R&D
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174053136

Sintx Intellectual Property is worth more than $230m as shown by Zimmers acquisition of Implex in 2003
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174493456:

Dr. Pezzotti member of Sintx scientific board and his research for Biomet
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174052660

Zimmer Biomet Hires Si3N4 Coatings Expert for its anti-infective dvision - December 2018
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174115529

Zimmer Biomet pays 2.5m certain R&D payment Q2 2017, Dr Bal's investment company loans $2.5m to Sintx.Q3, 2017
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174152867

Sintx - Morgan Ceramics partnership & NP Aerospace Connections
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174166246
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174166439

Evidence suggesting Sintx and NP Aerospace are working on female specific armor
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175356997


Mr Bond, they have a saying in Chicago: 'Once is happenstance. Twice is coincidence. The third time it's enemy action'.
One is an incident, two is a coincidence, three's a pattern, and four is enough for a warrant

It’s Two Buck Tuesday! One Buck Monday soon.

Ah, I’m back again after one / two years of taking a break from social Media platforms. I see that the same people are still posting the same persistent narratives here. Still, we see discussions about buyout strategies, buyout possibilities, upcoming catalysts, or supposed connections between employees of various companies, all in an attempt to make the stock appear more attractive.
It reminds me of what happened back in 2017, 2018 – with Amedica back then. There was a huge hype around a buyout just because the booths at a trade fair were located relatively close to each other – Zimmer Biomed and AMDA. Back then, it was a 100% guaranteed buyout.

It’s clear the mindset here hasn’t changed. Honestly, it’s hard not to feel sorry when you see how much time is invested here, supposedly with no agenda. Meanwhile, new strategies are constantly being developed to further a specific narrative, yet nothing ever comes of it.

The share price says it all. Adjusted for splits, it has fallen from 6, 7, 8, or even 900,000 per share, diluted now down to just 2 or 3 USD. Or how Management says "we secured financing".

I am out for the next two years and check again.

“Mergers”? This month should provide SINT with their 10th straight December 🏆️ award for tax loss selling!
One would be hard pressed to find a company for reaching this goal for 10 Straight Years!
They could even add as many as 100 shares to their buy back pump fake too.
To think that someone owns an $80. share from reading the fake it until the next reverse split solid as a marsh mellow DD on this board must make it’s provider proud.

With today’s volume I would think that the company may have added another 3 buck share or maybe they got a two buck one today to add to their Up to $500k buy back

It doesn’t appear as Ark bought any shares yet.
What could they as well as other funds be waiting for?
I mean from all of the tremendous DD here on the “could be” why not get in on the ground floor after all of these years?
Maybe their scam detector needs to be calibrated or is being effected by EMI?

Is “Two Buck Tuesday” a day early? It’s like Black Thursday!

Reverse Splits have had a tremendous financial burden for any shareholders in this fake it scam for a decade.
Why the SEC doesn’t shut crap like this down is beyond me.

My wife, a woman of… refined sensibilities, and our intellectually gifted son have relocated to Salt Lake City, Utah. This geographical anomaly places them in disconcerting proximity to the enigmatic SintX Technologies headquarters.

A premonition, delivered by my esteemed hair stylist (a woman of profound spiritual insight), foretold my destiny: to spread the gospel of truth through the enchanting melodies of a musical instrument. Alas, fate, as it often does, conspired against me. Instead, I stumbled upon a chilling revelation: the impending apocalypse, orchestrated by the insidious weakening of Earth's magnetic field.

Driven by a desperate desire to avert this impending catastrophe, I have dedicated myself to disseminating this critical information, albeit through this… less-than-prestigious digital platform. I accept the sobriquet "Carnac the Magnificent" with a degree of… amusement. The appellation "Magneto," however, while fitting, perhaps borders on the… obvious.

I understand that my pronouncements may be met with… skepticism. My theories may appear to be a bizarre amalgamation of conspiracy theories, pseudo-scientific gibberish, and anecdotes that would make a seasoned scientist weep. However, I assure you, there is a… method to the madness.

The salvation of humanity rests upon the shoulders of SintX Technologies and their revolutionary silicon nitride. Embrace this technological salvation, or face the inevitable… consequences.

Reverse mergers shareholders still have shares of whatever company and a reverse merger still triggers change in control. I dont think buyout is going to happen.

Could it be that Cathie Wood & Ark Invest's sold some Tesla shares to load their boat with SINT after spending months and months reading and trying to make any sense out of Boston’s DD?

I am thinking, probably NOT!

Simply amazing. Is this stuff available at Walmart yet? Tia

The year is 2042. The Earth's magnetic field, a shield against cosmic radiation and solar storms, has been steadily weakening. This, combined with increasingly intense space weather events, has created a perfect storm of energetic particles bombarding the planet.

In this environment, strange things are happening. In remote, geomagnetically sensitive regions, people are reporting unusual shifts in their identities. Men are experiencing subtle changes in their bodies and minds, a creeping feminization. Women, conversely, feel a masculine pull, their bodies responding in unexpected ways.

Scientists are baffled. Some point to the Hutchinson Effect, a poorly understood phenomenon involving electromagnetic fields and gravity, as a possible culprit. Others suspect the influence of the "dark side" of the planet – regions where the Earth's magnetic field is weakest, allowing these cosmic energies to exert a more profound effect.

Enter SINTX Technologies, a company specializing in advanced ceramics, particularly silicon nitride. Their research reveals that silicon nitride possesses unique electromagnetic properties. It can not only shield against harmful radiation but also subtly influence the flow of energy within the human body.

SINTX develops a range of personal protective devices and environmental shielding technologies. These innovations, infused with silicon nitride, offer a solution to the growing crisis. They can:

Personal Shields: Create wearable devices that counteract the effects of the weakened magnetic field and cosmic radiation, stabilizing individuals' biological processes.
Environmental Shielding: Develop materials and technologies to shield entire communities and infrastructure from the harmful effects of space weather and the Hutchinson Effect.
"Gender Realignment" Therapy: Utilize silicon nitride-based technologies to assist individuals experiencing unwanted gender-related changes, offering a safe and controlled method for navigating these complex shifts.
SINTX's innovations address a burgeoning market. As the Earth's magnetic field continues to weaken and space weather intensifies, the demand for solutions to these emerging challenges will skyrocket. SINTX, with its cutting-edge technology, is poised to become a leader in this critical new field, offering hope and stability to a world facing unprecedented change.

I also agree that Amda's assertion is quite plausible AND for the reason given. In fact, I can't find anything he says here, to disagree with. I would only add that if this is the case, I fully expect shareholders to be dumped on once again. The good news would be their misery finally ends.

amda
Yesterday 3:34 PM
$SINT now that filing is some extreme bullshit unless, of course, they are expecting a "change of control" a.k.a buyout, and they want to set themselves up handsomely.

“ Well you have to factor in the time he was at Sintx before”

Well you don’t have to factor that in.

What I would like to see “factored in” is all of them get a minimum wage salary and a percent of “net profit”.

If this fake it for 20 years scam has anything of value then there would be no fear for “Michael Jordan”.

Fishing in a fish bowl comes to mind.

“ Make more sense to sell” Absolutely nothing has made any sense in 20 years.

Using the words “making sense” and this pile of shit make absolutely zero sense.
Well unless you are challenged.

“ Maybe they'll bring” Elon Musk in and it won’t take another 25 years to make a profit.

The Company has been exploring new Zzzzz for 20+ years.

How’s that working out?

Oh you are right. Is that the hired stock pumper that made the last pump on the “buyback up to $500k of shares”?

I am sure that they have or will shortly buy a dozen shares to fulfill their “up to”.

One might wonder what his next pink sheet otc scam tactic is on the plate.

Perhaps they are relying on boston’s extensive research to find that next desired pump nugget.

Well you have to factor in the time he was at Sintx before when he successfully took Sintx public. I agree with AMDA that they are getting ready for a change in control. Thought a reverse merger with NP was in the cards, but they recently indicated a reverse merger maybe in the cards but indicated thatd be medical related assuming they unload industrial first. Of course they could be getting things ready for a future date. Maybe they'll bring Ned Medical into the fold instead of it raising Series A? Seems crazy at current valuation. But at 50+m valuation so Lind can exercise its warrants...less so. Make more sense to sell Industrial divisions first before doing something like that.

The Company is currently exploring new collaborations with strategic advisory partners to evaluate potential merger candidates, acquisitions, strategic partners and sale of business divisions, which could support SINTX’s ambitions to become a leader in the medical device market.
The Board of Directors also entered into an engagement agreement with Ascendiant Partners to evaluate strategic transactions including, but not limited to, acquisitions, strategic partnerships, sell of business divisions, and reverse merger opportunities.

Oh and AMDA, change in control only requires 50+% stake so not necessarily buyout. Eventually i expect ZImmer Biomet to get its hands on at least a portion of the tech.
now that filing is some extreme bullshit unless, of course, they are expecting a "change of control" a.k.a buyout, and they want to set themselves up handsomely.

Anyone know if Dr Luke Higgins is related to ZB board member Arthur Higgins? They really do look like father and son.


Quote Sources:
https://ir.sintx.com/news-events/press-releases/detail/240/sintx-technologies-provides-positive-strategic-business
https://www.sec.gov/ix?doc=/Archives/edgar/data/1269026/000149315224044728/form10-q.htm
https://stocktwits.com/amda/message/596438023

========================================

We already know Sintx and Morgan were working together. If there is going to be some sort of NP/Sintx merger, that just solidifies it. We also know Zimmer Biomet and Sintx have had a long standing relationship (going on 20 years) so as long as Sintx components for Arthroplasty are any good, Zimmer Biomet will come out from behind the curtain. With ZB comes ZimVie and I believe Solventum because of Bryan Hanson. Leaving only Cardinal Health which is suggested by Sintx hiring of Joseph Palomo who joined Sintx from Cardinal Health R&D division.

Morgan Ceramics = Aerospace products
Zimmer Biomet = Arthroplasty oriented products
ZimVie = Dental?
Solventum = Wound Care, Catheters, & possibly Cancer treatment products.
Ned Medical = Microspheres for cancer treatment
Cardinal Health = PPE & Medical protection apparel.
NP Aerospace = Armor plates & other possible products connected to TA&T.

========================================

Markets Si3n4/Sintx Ceramics can be used in (not comprehensive)

Otho Market = $64 billion
Personal Protective Equipment market = $79.53 billion
Global Catheter market = $55bn
Antibacterial market = $44.5bn
Wound Care market = $22.25bn
Biosensors Market = $28.9bn
Condom Market = $11.6bn
Dental Implant market = $4.99bn
Armor Materials Market = $13.59bn
Cancer Treatment (microspheres) = $5-$15bn

Total = $330bn-340bn

Sources:
https://web.archive.org/web/2024040...ogger.blogspot.com/2011/05/whos-next.html?m=1
https://orthospinenews.com/2021/01/...y-2025-as-acquisitions-surge-says-globaldata/
https://www.grandviewresearch.com/industry-analysis/personal-protective-equipment-ppe-market
https://www.grandviewresearch.com/industry-analysis/catheters-market-analysis
https://www.grandviewresearch.com/industry-analysis/wound-care-market
https://www.grandviewresearch.com/industry-analysis/biosensors-market
https://www.grandviewresearch.com/industry-analysis/condom-market
https://www.mordorintelligence.com/industry-reports/armor-materials-market
https://www.grandviewresearch.com/industry-analysis/dental-implants-market
https://www.youtube.com/watch?v=KeSa5vCj6Kw

You forgot the best part concerning Eric:
The amendment increased the Severance Compensation, .....from an amount equal to one times Executive’s highest Annual Salary with the Company during the preceding three-year period to an amount equal to two-times (2) times the Executive’s highest Annual Salary with the Company during the preceding three-year period, including the year of such termination.

He deserves it. After all, as we all know, he's already proven himself. He's been here how many years? Oops, weeks, months? Look at all the mega contracts, not to mention the amazing stock price for shareholders. Can't wait until the annual cc. I'm sure he'll do a swell job just like Sonny did....for himself!

Does the “nut sack sprayer” come with instructions on the frequency of its use?
Is it a several times a day when the EM crack is on its 3rd menstrual day?

“ increased the Severance Compensation”

“ change in control, all outstanding options, restricted stock and other such rights held by the executive will fully vest.”

“ Gregg Honigblum, the Company’s Chief Strategy Officer. Among other things, the Change in Control Agreement provides that upon the consummation of a change in control, all outstanding options, restricted stock and other such rights held by the executive will fully vest.”

More self enrichment. Bodes well for a fake it scam.
They are doing such a wonderful job.

https://ih.advfn.com/stock-market/NASDAQ/sintx-technologies-SINT/stock-news/95096836/form-8-k-current-report

Sorry, I don’t have “pioneer accounts” in my database. Please reword your post so that my computer driven brain can comprehend it.

Or it might be the current EMI’s effect.

“ It’s Boston's 911 information” A revocation won’t sit well with you.
However it will be funny

Highly contagious bird flu found at Wilton poultry farm, California officials confirm

Workers in white Haz-Mat style suits and wearing face masks worked for the past three days at a Wilton poultry farm due to an outbreak of highly pathogenic H5N1 bird flu, KCRA 3 has learned. The farm is owned by Perdue Foods out of Maryland according to Sacramento County tax records.

The California Department of Food and Agriculture in an email said that workers had worked yesterday with the U.S. Department of Agriculture at the farm to mitigate the spread of the virus. Neighbors tell KCRA 3 that the workers from both had been in and out of the farm for several days.

Footage shot by KCRA 3 shows signs saying that due to biosensitivity workers should walk through a clean water bath on the way in.

CDFA said that the birds on the property were euthanized, "a practice that is carried out rapidly to humanely alleviate suffering and help prevent the spread of the virus locally, regionally and nationally."
https://www.kcra.com/article/bird-flu-wilton-chicken-farm-sacramento-county/63176687

NEW OPPORTUNITIES/MARKETS/PRODUCTS
Several new collaborations in developing
products for wound care, cancer treatment,
and an antipathogenic coating for catheters.


Several new Collabs. We know Ned Medical is one of them. Several means more than two. Thus Sintx has more than one collab pertaining to wound care, coating for catheter, and likely cancer. Every product could have its own collab with 1 company or each collab could be with different companies. All 3 products mentioned are products Solventum sells which is ran by former Zimmer Biomet CEO Bryan Hanson.
In regards to PPE they could be working with Cardinal Heath and/or Solventum.

The correct approach is to go to 3M and try to license into their filtrete line or any other filter maker. That’s where the money is if adding sini doesn’t decrease airflow by a significant amount

3M would be game changer. F any other company. You get them, you get the kings loot. Everyone comes for it to license. So the issue then becomes sonny being able to get it done. Need laser focus and keep knocking until they answer

Thanks Madg for those words. Solventum of course is 3M's medical division spun off. With Mystery X disease in Congo, rising Mpox, & rising Bird Flu, Sintx needs to get moving with its partner(s) before more lives are lost which could have been prevented.

Quote Sources:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=154542598
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=154543575
https://d1io3yog0oux5.cloudfront.ne...INTX+Corporate+Overview+-+Jan+'24+-+Rev+J.pdf
https://news.3m.com/Bryan-Hanson-Named-CEO-of-3Ms-Health-Care-Business-Group

========================================

Here is a collection of my research going over multiple subjects including Sintx connections with Zimmer Biomet, Solventum, Morgan Ceramics, & NP Aerospace. Includes other research topics as well.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175357996

========================================

We already know Sintx and Morgan were working together. If there is going to be some sort of NP/Sintx merger, that just solidifies it. We also know Zimmer Biomet and Sintx have had a long standing relationship (going on 20 years) so as long as Sintx components for Arthroplasty are any good, Zimmer Biomet will come out from behind the curtain. With ZB comes ZimVie and I believe Solventum because of Bryan Hanson. Leaving only Cardinal Health which is suggested by Sintx hiring of Joseph Palomo who joined Sintx from Cardinal Health R&D division.

Morgan Ceramics = Aerospace products
Zimmer Biomet = Arthroplasty oriented products
ZimVie = Dental?
Solventum = Wound Care, Catheters, & possibly Cancer treatment products.
Ned Medical = Microspheres for cancer treatment
Cardinal Health = PPE & Medical protection apparel.
NP Aerospace = Armor plates & other possible products connected to TA&T.

========================================

Markets Si3n4/Sintx Ceramics can be used in (not comprehensive)

Otho Market = $64 billion
Personal Protective Equipment market = $79.53 billion
Global Catheter market = $55bn
Antibacterial market = $44.5bn
Wound Care market = $22.25bn
Biosensors Market = $28.9bn
Condom Market = $11.6bn
Dental Implant market = $4.99bn
Armor Materials Market = $13.59bn
Cancer Treatment (microspheres) = $5-$15bn

Total = $330bn-340bn

Sources:
https://web.archive.org/web/2024040...ogger.blogspot.com/2011/05/whos-next.html?m=1
https://orthospinenews.com/2021/01/...y-2025-as-acquisitions-surge-says-globaldata/
https://www.grandviewresearch.com/industry-analysis/personal-protective-equipment-ppe-market
https://www.grandviewresearch.com/industry-analysis/catheters-market-analysis
https://www.grandviewresearch.com/industry-analysis/wound-care-market
https://www.grandviewresearch.com/industry-analysis/biosensors-market
https://www.grandviewresearch.com/industry-analysis/condom-market
https://www.mordorintelligence.com/industry-reports/armor-materials-market
https://www.grandviewresearch.com/industry-analysis/dental-implants-market
https://www.youtube.com/watch?v=KeSa5vCj6Kw

Space weather, EM induced erectile disfunction.

I'm going to keep pounding the table, as I have given up on pounding myself about the growing cause of infertility on earth and how SintX technologies could address this multi trillion dollar market with their special nut sack sprayer that can protect sea men against harmful radiation from the sun. And let's be honest, who among us hasn't felt the cosmic rays zap our mojo?"

Based on my analysis of the

Reverse~Splits on this trash, it’s about every 2 years.

It might not make it to the second year this time.

Proceed with Caution

im going to keep pounding the table about the growing threat of more than one pandemic as Solar Cycle 25 weakens and 26 grows.

NEW OPPORTUNITIES/MARKETS/PRODUCTS
Several new collaborations in developing
products for wound care, cancer treatment,
and an antipathogenic coating for catheters.


Several new Collabs. We know Ned Medical is one of them. Several means more than two. Thus Sintx has more than one collab pertaining to wound care, coating for catheter, and likely cancer. Every product could have its own collab with 1 company or each collab could be with different companies. All 3 products mentioned are products Solventum sells which is ran by former Zimmer Biomet CEO Bryan Hanson.
In regards to PPE they could be working with Cardinal Heath and/or Solventum.

The correct approach is to go to 3M and try to license into their filtrete line or any other filter maker. That’s where the money is if adding sini doesn’t decrease airflow by a significant amount

3M would be game changer. F any other company. You get them, you get the kings loot. Everyone comes for it to license. So the issue then becomes sonny being able to get it done. Need laser focus and keep knocking until they answer

Thanks Madg for those words. Solventum of course is 3M's medical division spun off. With Mystery X disease in Congo, rising Mpox, & rising Bird Flu, Sintx needs to get moving with its partner(s) before more lives are lost which could have been prevented.

Quote Sources:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=154542598
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=154543575
https://d1io3yog0oux5.cloudfront.ne...INTX+Corporate+Overview+-+Jan+'24+-+Rev+J.pdf
https://news.3m.com/Bryan-Hanson-Named-CEO-of-3Ms-Health-Care-Business-Group


========================================

Here is a collection of my research going over multiple subjects including Sintx connections with Zimmer Biomet, Solventum, Morgan Ceramics, & NP Aerospace. Includes other research topics as well.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175357996

========================================

We already know Sintx and Morgan were working together. If there is going to be some sort of NP/Sintx merger, that just solidifies it. We also know Zimmer Biomet and Sintx have had a long standing relationship (going on 20 years) so as long as Sintx components for Arthroplasty are any good, Zimmer Biomet will come out from behind the curtain. With ZB comes ZimVie and I believe Solventum because of Bryan Hanson. Leaving only Cardinal Health which is suggested by Sintx hiring of Joseph Palomo who joined Sintx from Cardinal Health R&D division.

Morgan Ceramics = Aerospace products
Zimmer Biomet = Arthroplasty oriented products
ZimVie = Dental?
Solventum = Wound Care, Catheters, & possibly Cancer treatment products.
Ned Medical = Microspheres for cancer treatment
Cardinal Health = PPE & Medical protection apparel.
NP Aerospace = Armor plates & other possible products connected to TA&T.

========================================

Markets Si3n4/Sintx Ceramics can be used in (not comprehensive)

Otho Market = $64 billion
Personal Protective Equipment market = $79.53 billion
Global Catheter market = $55bn
Antibacterial market = $44.5bn
Wound Care market = $22.25bn
Biosensors Market = $28.9bn
Condom Market = $11.6bn
Dental Implant market = $4.99bn
Armor Materials Market = $13.59bn
Cancer Treatment (microspheres) = $5-$15bn

Total = $330bn-340bn

Sources:
https://web.archive.org/web/2024040...ogger.blogspot.com/2011/05/whos-next.html?m=1
https://orthospinenews.com/2021/01/...y-2025-as-acquisitions-surge-says-globaldata/
https://www.grandviewresearch.com/industry-analysis/personal-protective-equipment-ppe-market
https://www.grandviewresearch.com/industry-analysis/catheters-market-analysis
https://www.grandviewresearch.com/industry-analysis/wound-care-market
https://www.grandviewresearch.com/industry-analysis/biosensors-market
https://www.grandviewresearch.com/industry-analysis/condom-market
https://www.mordorintelligence.com/industry-reports/armor-materials-market
https://www.grandviewresearch.com/industry-analysis/dental-implants-market
https://www.youtube.com/watch?v=KeSa5vCj6Kw

My wife, a woman of… refined sensibilities, and our intellectually gifted son have relocated to Salt Lake City, Utah. This geographical anomaly places them in disconcerting proximity to the enigmatic SintX Technologies headquarters.

A premonition, delivered by my esteemed hair stylist (a woman of profound spiritual insight), foretold my destiny: to spread the gospel of truth through the enchanting melodies of a musical instrument. Alas, fate, as it often does, conspired against me. Instead, I stumbled upon a chilling revelation: the impending apocalypse, orchestrated by the insidious weakening of Earth's magnetic field.

Driven by a desperate desire to avert this impending catastrophe, I have dedicated myself to disseminating this critical information, albeit through this… less-than-prestigious digital platform. I accept the sobriquet "Carnac the Magnificent" with a degree of… amusement. The appellation "Magneto," however, while fitting, perhaps borders on the… obvious.

I understand that my pronouncements may be met with… skepticism. My theories may appear to be a bizarre amalgamation of conspiracy theories, pseudo-scientific gibberish, and anecdotes that would make a seasoned scientist weep. However, I assure you, there is a… method to the madness.

The salvation of humanity rests upon the shoulders of SintX Technologies and their revolutionary silicon nitride. Embrace this technological salvation, or face the inevitable… consequences.

We are currently on solar cycle 25 and I believe that once we enter solar cycle 29-9.417Z/3 that the SINT share price will rocket.
However this will be after the next 2 Reverse~Splts.
Thus at the age of 106 Dick van Dyke might want to move some of his future retirement funds into SINT.
All of this is just my opinion after many many hours of research.

Please see my board for more information and follow me.

“ Knocking On Our Door“ is two bucks a share.

Perhaps 96 year old Dick Van Dyke should buy a few SINT shares to take with him.